Clinical Trial Update: ADAR1 Expression Level in Rectal Cancer

View source ↗

Summary

A recruiting clinical trial at Necmettin Erbakan University is investigating ADAR1 expression levels in rectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Adenocarcinoma
• Rectal Cancer

Snippet

Sponsor: Necmettin Erbakan University | Conditions: Rectum Cancer, Adenocarcinoma | Status: RECRUITING